ARTICLE
16 August 2016

FDA Issues Guidance On Human Food Safety Evaluation Of New Animal Drugs

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
The guidance describes the types of information that FDA's Center for Veterinary Medicine recommends sponsors provide to address the human food safety of new animal drugs used in food-producing animals.
United States Food, Drugs, Healthcare, Life Sciences

In the July 21, 2016, Federal Register, FDA announced the availability of a draft revised guidance for industry titled "General Principles for Evaluating the Human Food Safety of New Animal Drugs Used in Food-Producing Animals." The guidance describes the types of information that FDA's Center for Veterinary Medicine recommends sponsors provide to address the human food safety of new animal drugs used in food-producing animals. Specifically, the guidance provides an overview of the process for the human food safety evaluation, including: (i) determination of an acceptable daily intake; (ii) calculation of safe concentrations; (iii) assignment of a tolerance; (iv) calculation of a withdrawal period and a milk discard time; and (v) evaluation of carcinogenic compounds. Comments are due September 19, 2016.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More